hanimune
2 known investors
Find your way into hanimune
Sign up to see every warm intro you have to hanimune
- Paths you didn't know you had: your email and LinkedIn already hold routes to the hanimune team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Hanimune Therapeutics develops therapeutics for food allergy prevention and tolerance support for pediatric and adult patients, drawing on immunological science and food protein research.
Founders & leadership
Investors · 2
BioAdvancelisted by BioAdvanceConshohocken · $500K – $1.5M
How we know: BioAdvance's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
Robin Hood Ventureslisted by Robin Hood VenturesPhiladelphia · $250K – $1Mvia Pitou Devgon · inferred
How we know: Robin Hood Ventures's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
Frequently asked questions
- What does hanimune do?
- Hanimune Therapeutics develops therapeutics for food allergy prevention and tolerance support for pediatric and adult patients, drawing on immunological science and food protein research.
- Who founded hanimune?
- hanimune was founded by Meenal Lele.
- Who are hanimune's investors?
- hanimune's investors include BioAdvance, Robin Hood Ventures.

